| Identification | Back Directory | [Name]
Xenazoic | [CAS]
1174-11-4 | [Synonyms]
Xenazoic
Xenalamine
Benzoic acid, p-[ (.alpha.-ethoxy-p-phenylphenacyl)amino]-
4-[[1-ethoxy-2-oxo-2-(4-phenylphenyl)ethyl]amino]benzoic acid
4-[[1-ethoxy-2-keto-2-(4-phenylphenyl)ethyl]amino]benzoic acid | [MDL Number]
MFCD00866917 | [MOL File]
1174-11-4.mol |
| Chemical Properties | Back Directory | [Melting point ]
192° (dec) | [storage temp. ]
Store at -20°C | [solubility ]
Acetone (Slightly, Sonicated), DMSO (Slightly) | [form ]
Solid | [color ]
Pale Red | [Stability:]
Temperature Sensitive |
| Hazard Information | Back Directory | [Uses]
Xenazoic Acid has been identified in virtual screening against TRβ agonist binding pocket. | [Brand name]
Cv 58903;Xenalmine;Xenovis. | [World Health Organization (WHO)]
Xenazoic acid, an antiviral agent, was introduced in the early
1960s. Its use was associated with hepatic toxicity which resulted in its withdrawal
from the market in at least two countries in 1965. WHO has no information to
suggest that xenazoic acid remains commercially available. |
|
|